Suppr超能文献

首次用于测定水性样品中抗癌药物的实验室间比对实验。

First inter-laboratory comparison exercise for the determination of anticancer drugs in aqueous samples.

作者信息

Heath Ester, Česen Marjeta, Negreira Noelia, de Alda Miren Lopez, Ferrando-Climent Laura, Blahova Lucie, Nguyen Tung Viet, Adahchour Mohamed, Ruebel Achim, Llewellyn Neville, Ščančar Janez, Novaković Srdjan, Mislej Vesna, Stražar Marjeta, Barceló Damià, Kosjek Tina

机构信息

Jožef Stefan Institute, Jamova 39, 1000, Ljubljana, Slovenia.

International Postgraduate School Jožef Stefan, Jamova 39, Ljubljana, Slovenia.

出版信息

Environ Sci Pollut Res Int. 2016 Aug;23(15):14692-704. doi: 10.1007/s11356-015-4982-9. Epub 2015 Jul 15.

Abstract

The results of an inter-laboratory comparison exercise to determine cytostatic anticancer drug residues in surface water, hospital wastewater and wastewater treatment plant effluent are reported. To obtain a critical number of participants, an invitation was sent out to potential laboratories identified to have the necessary knowledge and instrumentation. Nine laboratories worldwide confirmed their participation in the exercise. The compounds selected (based on the extent of use and laboratories capabilities) included cyclophosphamide, ifosfamide, 5-fluorouracil, gemcitabine, etoposide, methotrexate and cisplatinum. Samples of spiked waste (hospital and wastewater treatment plant effluent) and surface water, and additional non-spiked hospital wastewater, were prepared by the organising laboratory (Jožef Stefan Institute) and sent out to each participant partner for analysis. All analytical methods included solid phase extraction (SPE) and the use of surrogate/internal standards for quantification. Chemical analysis was performed using either liquid or gas chromatography mass (MS) or tandem mass (MS/MS) spectrometry. Cisplatinum was determined using inductively coupled plasma mass spectrometry (ICP-MS). A required minimum contribution of five laboratories meant that only cyclophosphamide, ifosfamide, methotrexate and etoposide could be included in the statistical evaluation. z-score and Q test revealed 3 and 4 outliers using classical and robust approach, respectively. The smallest absolute differences between the spiked values and the measured values were observed in the surface water matrix. The highest within-laboratory repeatability was observed for methotrexate in all three matrices (CV ≤ 12 %). Overall, inter-laboratory reproducibility was poor for all compounds and matrices (CV 27-143 %) with the only exception being methotrexate measured in the spiked hospital wastewater (CV = 8 %). Random and total errors were identified by means of Youden plots.

摘要

本文报告了一项实验室间比对实验的结果,该实验旨在测定地表水、医院废水和污水处理厂出水 中的细胞毒性抗癌药物残留。为了获得足够数量的参与者,研究团队向已确认具备相关知识和仪器设备的潜在实验室发出了邀请。全球共有9个实验室确认参与了此次实验。根据药物使用范围和实验室能力,选定的化合物包括环磷酰胺、异环磷酰胺、5-氟尿嘧啶、吉西他滨、依托泊苷、甲氨蝶呤和顺铂。加标废物(医院废水和污水处理厂出水)和地表水的样本,以及额外的未加标医院废水样本,由组织实验室(约瑟夫·施特凡研究所)制备,并分发给每个参与实验室进行分析。所有分析方法均包括固相萃取(SPE),并使用替代/内标进行定量。化学分析采用液相或气相色谱-质谱(MS)或串联质谱(MS/MS) 法。顺铂采用电感耦合等离子体质谱(ICP-MS)测定。由于要求至少有五个实验室参与,因此只有环磷酰胺、异环磷酰胺、甲氨蝶呤和依托泊苷可纳入统计评估。Z 分数和 Q 检验分别使用经典方法和稳健方法识别出3个和4个异常值。在地表水基质中,加标值与测量值之间观察到的绝对差异最小。在所有三种基质中,甲氨蝶呤的实验室内重复性最高(CV≤12%)。总体而言,除了加标医院废水中测定的甲氨蝶呤(CV = 8%)外,所有化合物和基质的实验室间再现性均较差(CV为27%-143%)。通过尤登图识别出了随机误差和总误差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验